The effects of add-on therapy of Phyllanthus Emblica (Amla) on laboratory confirmed COVID-19 Cases: A randomized, double-blind, controlled trial

OBJECTIVE: This randomized, double-blind, controlled trial (RCT) aimed to evaluate the effect of Phyllanthus Emblica (Amla) as an add-on therapy on COVID-19_ related biomarkers and clinical outcomes in COVID-19 patients. METHODS: In this RCT, sixty-one patients were randomly assigned into two arms [...

Descripción completa

Detalles Bibliográficos
Autores principales: Varnasseri, Mehran, Siahpoosh, Amir, Hoseinynejad, Khojasteh, Amini, Fetemeh, Karamian, Masoumeh, Yad, Mohammad Jafar Yad, Cheraghian, Bahman, Khosravi, Azar Dokht
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Ltd. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8799474/
https://www.ncbi.nlm.nih.gov/pubmed/35093510
http://dx.doi.org/10.1016/j.ctim.2022.102808

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8799474/
https://www.ncbi.nlm.nih.gov/pubmed/35093510
http://dx.doi.org/10.1016/j.ctim.2022.102808

Ejemplares similares